- Home >
- Clinicals Trials >
- AML LI-1
AML LI-1
A PROGRAMME OF DEVELOPMENT FOR OLDER PATIENTS WITH ACUTE MYELOID LEUKAEMIA AND HIGH RISK MYELODYSPLASTIC SYNDROME
- Open at Saint-Cloud since : 03/04/2014
- Target : Adult
- Phase : Phase II/III
Trial description
The LI-1 Protocol is an international ongoing therapeutic evaluation program for elderly patients with high-risk AML and MDS who are considered ineligible for conventional intensive chemotherapy. Patients are initially included in a randomized multi-arm Phase II trial, which compares multiple new therapeutic options to the standard treatment (low-dose Aracytine).
Main investigator
